Dasatinib Metabolite F |
|
| Synonyms: N-Deshydroxyethyl Dasatinib; N-(2-Chloro-6-methylphenyl)-2-[[2-methyl-6-(1-piperazinyl)-4-pyrimidinyl]amino]-5-thiazolecarboxamide; Dasatinib metabolite M4; | |
| Cat. No.: D25015 | CAS No.: 910297-51-7 |
| MDL.: | Formula: C20H22ClN7OS |
| F.W.443.95 | Purity: 99% |
| Storage: Refrigerator | |
|   | |
| Catalog Number: | D25015 | CAS No.: | 910297-51-7 | |
| MDL: | Formula: | C20H22ClN7OS | ||
| F.W.: | 443.95 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | White to Off-White Solid | M.P.: | >270°C (dec.) | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO, Methanol (Sparingly) | Stability: | ||
| Storage: | Refrigerator | Category: | Reference Standard | |
| Reference: | Trentham, D., et al.: Biochem. J., 126, 635 (1972), Matsuguchi, T., et al.: J. Biol. Chem., 269, 5016 (1994), Berman, E., et al.: Leukemia Res., 24, 289 (2000), Tokarski, J., et al.: Cancer Res., 2006, 66, 5790 (2006), | |||
| Application: | A metabolite of Dasatinib. Used in the treatment of cancers and immune diseases. | |||
| Category: | Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, | |||








